Inventor · disambiguated record
Jeffrey D. Hasday
Also filed as: HASDAY JEFFREY · HASDAY JEFFREY D
6 granted patents·4 pending applications·29 citations·filing 2017–2024
80Inventor score
Files withUNIV MARYLAND10
Top patents by PatentIndex Score
10 records- 0196US11357781B2Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereofUNIV MARYLAND·Filed 2021·Granted Jun 14, 2022·10 cites·21 claims
- 0296US11078171B2Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitorsUNIV MARYLAND·Filed 2020·Granted Aug 3, 2021·13 cites·13 claims
- 0394US11718595B2Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitorsUNIV MARYLAND·Filed 2021·Granted Aug 8, 2023·4 cites·19 claims
- 0493US11911393B2Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereofUNIV MARYLAND·Filed 2023·Granted Feb 27, 2024·1 cites·17 claims
- 0591US11911392B2Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereofUNIV MARYLAND·Filed 2022·Granted Feb 27, 2024·1 cites·20 claims
- 0684US2025100985A1NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORSUNIV MARYLAND·Filed 2024·Application pending·0 cites
- 0782US2024366619A1NON-CATALYTIC SUBSTRATE-SELECTIVE p38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOFUNIV MARYLAND·Filed 2024·Application pending·0 cites
- 0881US12202810B2Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitorsUNIV MARYLAND·Filed 2023·Granted Jan 21, 2025·0 cites·18 claims
- 0962US2019151324A1NON-CATALYTIC SUBSTRATE-SELECTIVE P38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOFUNIV MARYLAND·Filed 2017·Application pending·0 cites
- 1053US2023140941A1Non-atp/catalytic site p38 mitogen activated protein kinase inhibitorsUNIV MARYLAND·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →